Our Centres
Our Doctors
Your state: SA |
Our Centres
Our Doctors
Dr Andrew Potter
MBBS, BMedSc(Hons), FRANZCR, Radiation Oncologist
For patients/carers
For doctors
MBBS, BMedSc(Hons), FRANZCR, Radiation Oncologist
Locations
Clinical interests
- Blood cancer
- Breast cancer
- Gynaecological cancer
- Skin cancer
- Brain cancer
- Spinal cancer
Treatment techniques
- Radiation therapy
Languages
Fluent
- English
Biography
Clinical interests in breast, lung, skin, urological, gynaecological, haematological, prostate, and central nervous system (CNS) cancers, plus palliative radiation therapy.
Dr Andrew Potter studied at the University of Adelaide, graduating with a Bachelor of Medical Science (Honours) in 1998 and Bachelor of Medicine and Bachelor of Surgery in 2000. He undertook his specialist training in Radiation Oncology at the Royal Adelaide Hospital, before working as a Clinical Research Fellow at the Princess Margaret Hospital in Toronto, Canada, from 2008-2009 where he was awarded the RS Bush Award for Academic Excellence.
Dr Potter returned to Adelaide as a Consultant Radiation Oncologist at the Royal Adelaide Hospital in 2009. There he worked in a multidisciplinary cancer centre, developing sub-specialty knowledge in stereotactic radiation therapy treating children and young adults with cancer, and disease sites including melanoma, sarcoma, and malignancies involving the haematological and central nervous systems.
He maintains a clinical interest in all diseases where radiation therapy can be applied, including breast, lung, skin, gynaecological, central nervous system, and haematological cancers.
Dr Potter is closely involved in education and training of radiation therapy students, medical students and radiation oncology registrars. He lectures at the University of South Australia and is an examiner for the RANZCR Faculty of Radiation Oncology.
Dr Potter supports a variety of research activities, including the supervision of Honours and PhD students, clinical trials, and has contributed to a number of peer-reviewed research papers.
More information
- RANZCR
- ASTRO
- ESTRO
- TROG
- COGNO
- ANZGOG
- Member of the ESTRO Radiobiology Course teaching faculty
- Devlin, E. J., Whitford, H. S., Denson, L. A., & Potter, A. E. (2020). ‘Measuring up’: A comparison of two response expectancy assessment formats completed by men treated with radiotherapy for prostate cancer. Journal of Psychosomatic Research, 132, Article 109979. https://doi.org/10.1016/j.jpsychores.2020.109979
- Mullin, S. J., Lochhead, A., Haddad, R., Kippen, J., Paddon, V., Joshua, A., Koh, K., Potter, A., & Fogarty, G. B. (2019). Keratoacanthomas following definitive volumetric modulated arc radiotherapy for skin field cancerization. International Journal of Radiology & Radiation Therapy, 6(6), 225–232. https://doi.org/10.15406/ijrrt.2019.06.00252
- Fogarty, G. B., Christie, D., & Potter, A. E. (2019). Volumetric modulated arc therapy (VMAT) for extended skin field cancerisation (ESFC): Radiobiological learnings from unique patient cases. International Journal of Radiology & Radiation Therapy, 6(5), 156–162. https://doi.org/10.15406/ijrrt.2019.06.00239
- Potter, A., Price, M., Papworth, D., Melven, L., Shaw, I., Hayles, M., Hellyer, J., Buman, K., Kaminski, A., Schlect, D., Wong, B., Christie, D., Izard, M. A., Holt, N. E., & Fogarty, G. B. (2019). A technique for treating extended skin field cancerisation using volumetric modulated arc therapy. International Journal of Radiology & Radiation Therapy, 6(4), 111–119. https://doi.org/10.15406/ijrrt.2019.06.00230
- Devlin, E. J., Whitford, H. S., Denson, L. A., & Potter, A. E. (2019). ‘Just as I expected’: A longitudinal cohort study of the impact of response expectancies on side effect experiences during radiotherapy for prostate cancer. Journal of Pain and Symptom Management, 57(2), 273–281.e4. https://doi.org/10.1016/j.jpainsymman.2018.11.002
- Potter, A. E., Baker, C., Shumack, S., Sinclair, R., Curran, W. J., Christie, D., Wong, B., Foley, P., O’Brien, P., & Spelman, L.; on behalf of the National Dermatology Radiation Oncology Registry (NDROR) investigators and sites. (2022). Preliminary efficacy and safety analysis: 12-month results in 83 patients using a novel approach of widefield radiation therapy for extensive skin field cancerization with or without keratinocyte cancers. Journal of Dermatological Treatment, 33(5), 2634–2642. https://doi.org/10.1080/09546634.2022.2067814
